The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Nobivac DHP

. Lyophilisate for suspension for injection

Intervet Ireland LimitedVPA10996/174/001

Main Information

Trade NameNobivac DHP
Active SubstancesCanine distemper virus, strain onderstepoort
Canine adenovirus type 2 strain manhattan lpv3 (live)
Canine parvovirus strain 154 (live)
Dosage FormLyophilisate for suspension for injection
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/174/001

Group Information

ATC CodeQI07AD02 canine distemper virus + canine adenovirus + canine parvovirus
Therapeutic ClassImmunological - Live Vaccine


Licence Issued12/11/2004
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back